Tower Research Capital LLC (Trc) Athira Pharma, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Athira Pharma, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 13,392 shares of ATHA stock, worth $5,892. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,392
Previous 5,115
161.82%
Holding current value
$5,892
Previous $2,000
250.0%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ATHA
# of Institutions
62Shares Held
18.8MCall Options Held
17.2KPut Options Held
800-
Perceptive Advisors LLC New York, NY5.4MShares$2.38 Million0.11% of portfolio
-
Bml Capital Management, LLC Zionsville, IN2.78MShares$1.22 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.56MShares$684,9260.0% of portfolio
-
Simplify Asset Management Inc. New York, NY1.49MShares$656,8280.05% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.49MShares$656,8280.87% of portfolio
About Athira Pharma, Inc.
- Ticker ATHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,817,700
- Market Cap $16.6M
- Description
- Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...